Euretina Congress

Genetic testing and counseling are advisable in family members of patients with choroideremia, particularly female members of childbearing age, according to a poster presented at the virtual Euretina congress.

The Gisbert Richard Lecture, delivered at the virtual Euretina congress by Heinrich Heimann, MD, focused on visual function after retinal detachment surgery.

In this video, Arshad Khanani, MD, speaks about one of his presentations at the virtual Euretina congress in which he reported the results of an analysis of retinal fluid and visual acuity outcomes in the Archway trial.

In this video from the virtual Euretina congress, Gemmy Cheung, MD, speaks about the new criteria for the diagnosis and management of polypoidal choroidal vasculopathy, or PCV.

Topline results from the phase 3 DERBY and OAKS trials, released by Apellis Pharmaceuticals earlier this month, showed potential for pegcetacoplan to significantly reduce lesion growth in geographic atrophy.

In this video from the virtual Euretina congress, Tunde Peto, MD, PhD, speaks of how the management of diabetes-related eye disease can be optimized during the pandemic, minimizing in-person visits to ensure safety for patients and staff.

In this video, Arshad Khanani, MD, speaks about a post hoc comparative assessment of patients treated with brolucizumab vs. aflibercept in the HAWK and HARRIER phase 3 studies.

At the virtual Euretina congress, Ogugua Okonkwo, MD, FRCS, delivered the Kreissig Lecture, focusing on the potential of neuroprotection as a treatment strategy for nonarteritic central retinal artery occlusion.

Initial findings from the real-world PERCEIVE study of voretigene neparvovec in patients with RPE65 mutation-associated inherited retinal dystrophy show safety and efficacy in line with those observed in pivotal trials.

Should patients with nonproliferative diabetic retinopathy be treated early with prophylactic anti-VEGF therapy?